126 related articles for article (PubMed ID: 36948988)
1. First clinical implementation of Yttrium-90 Disc Brachytherapy after FDA clearance.
Finger PT; Stewart R; Rivard MJ; Beers RJ; Kamen J; Lama S; Chin KJ; Mohney K; Welles TS; Sauerwein WAG; Rosenzweig K
Brachytherapy; 2023; 22(3):416-427. PubMed ID: 36948988
[TBL] [Abstract][Full Text] [Related]
2. Yttrium-90 Episcleral Plaque Brachytherapy for Choroidal Melanoma.
Finger PT
J Vitreoretin Dis; 2024; 8(2):210-214. PubMed ID: 38465362
[No Abstract] [Full Text] [Related]
3. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
4. Ocular malignancies treated with iodine-125 low dose rate (LDR) brachytherapy at a single high-volume institution: A retrospective review.
Richards Z; Nguyen ML; Kutteh M; Ahmad S; Henson C; Firestone B; Herman TS; Herman TF
Med Dosim; 2022 Autumn; 47(3):273-279. PubMed ID: 35644778
[TBL] [Abstract][Full Text] [Related]
5. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
Lee YC; Lin SC; Kim Y
Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
[TBL] [Abstract][Full Text] [Related]
6. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
7. A novel conformal superficial high-dose-rate brachytherapy device for the treatment of nonmelanoma skin cancer and keloids.
Ferreira C; Johnson D; Rasmussen K; Leinweber C; Ahmad S; Jung JW
Brachytherapy; 2017; 16(1):215-222. PubMed ID: 27720205
[TBL] [Abstract][Full Text] [Related]
8. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
9. Juxtapapillary and circumpapillary choroidal melanoma: globe-sparing treatment outcomes with iodine-125 notched plaque brachytherapy.
Hegde JV; McCannel TA; McCannel CA; Lamb J; Wang PC; Veruttipong D; Almanzor R; Demanes DJ; Kamrava M
Graefes Arch Clin Exp Ophthalmol; 2017 Sep; 255(9):1843-1850. PubMed ID: 28597076
[TBL] [Abstract][Full Text] [Related]
10. Intensity modulated high dose rate ocular brachytherapy using Se-75.
Dupere JM; Munro JJ; Medich DC
Brachytherapy; 2021; 20(6):1312-1322. PubMed ID: 34561174
[TBL] [Abstract][Full Text] [Related]
11. A five-year study of slotted eye plaque radiation therapy for choroidal melanoma: near, touching, or surrounding the optic nerve.
Finger PT; Chin KJ; Tena LB
Ophthalmology; 2012 Feb; 119(2):415-22. PubMed ID: 22133796
[TBL] [Abstract][Full Text] [Related]
12. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
13. Fractionated high-dose-rate and pulsed-dose-rate brachytherapy: first clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate.
Levendag PC; Schmitz PI; Jansen PP; Senan S; Eijkenboom WM; Sipkema D; Meeuwis CA; Kolkman-Deurloo IK; Visser AG
Int J Radiat Oncol Biol Phys; 1997 Jun; 38(3):497-506. PubMed ID: 9231672
[TBL] [Abstract][Full Text] [Related]
14. Development and dosimetric assessment of a patient-specific elastic skin applicator for high-dose-rate brachytherapy.
Park SY; Kang S; Park JM; An HJ; Oh DH; Kim JI
Brachytherapy; 2019; 18(2):224-232. PubMed ID: 30528742
[TBL] [Abstract][Full Text] [Related]
15. Radiobiology for eye plaque brachytherapy and evaluation of implant duration and radionuclide choice using an objective function.
Gagne NL; Leonard KL; Rivard MJ
Med Phys; 2012 Jun; 39(6):3332-42. PubMed ID: 22755715
[TBL] [Abstract][Full Text] [Related]
16. A multiwell applicator for conformal brachytherapy of superficial skin tumors: A simulation study.
Pashazadeh A; Robatjazi M; Castro NJ; Friebe M
Skin Res Technol; 2020 Jul; 26(4):537-541. PubMed ID: 31883147
[TBL] [Abstract][Full Text] [Related]
17. Patterns of radiotherapy practice for patients with squamous carcinoma of the uterine cervix: patterns of care study.
Eifel PJ; Moughan J; Owen J; Katz A; Mahon I; Hanks GE
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(2):351-8. PubMed ID: 10030261
[TBL] [Abstract][Full Text] [Related]
18. First clinical implementation of GammaTile permanent brain implants after FDA clearance.
Ferreira C; Sterling D; Reynolds M; Dusenbery K; Chen C; Alaei P
Brachytherapy; 2021; 20(3):673-685. PubMed ID: 33487560
[TBL] [Abstract][Full Text] [Related]
19. Extrascleral extension of choroidal melanoma: post-enucleation high-dose-rate interstitial brachytherapy of the orbit.
Finger PT; Tena LB; Semenova E; Aridgides P; Choi WH
Brachytherapy; 2014; 13(3):275-80. PubMed ID: 24139892
[TBL] [Abstract][Full Text] [Related]
20. A Systematic Comparison of Dose Distributions Delivered in
Trofimov AV; Aronow ME; Gragoudas ES; Keane FK; Kim IK; Shih HA; Bhagwat MS
Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):501-510. PubMed ID: 35878716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
